Germline mutations of VHL account for more than 95% of the patients affected by VHL (5% have somatic inactivation of the VHL gene in sporadically occurring hemangioblastomas and renal cell carcinomas) (9). This evidence concerns the gene VHL and hereditary clear cell renal cell carcinoma.